Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Dearnaley

Showing results (11-20 of 185) with videos related to

Pageof 19
Sort By:
The Journal of Physiology|December 1, 1970
The effect of cocaine and normetanephrine on the overflow of noradrenaline from the isolated blood-perfused cat spleenH Cripps, D P Dearnaley
Arzneimittel-Forschung|September 1, 1971
A technique for measuring exploratory activity in rats: some effects of chlorpromazine and chlordiazepoxideJ Cole, D P Dearnaley
Cancer Treatment Reviews|June 6, 2003
Radical radiotherapy for prostate cancerC C Parker, D P Dearnaley
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 13, 2019
Seven or less Fractions is Not the Standard of Care for Intermediate-Risk Prostate CancerA C Tree, D P Dearnaley
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 27, 2007
Question of dose, fractionation and technique: ingredients for testing hypofractionation in prostate cancer--the CHHiP trialV S Khoo, D P Dearnaley
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1993
Prostate cancer: pelvic nodes revisited--sites, incidence and prospects for treatment with radiotherapyA J Neal, D P Dearnaley
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 3, 1999
The management of PSA failure after radical radiotherapy for localized prostate cancerC C Parker, D P Dearnaley
Lancet (London, England)|January 21, 1978
Plasmapheresis for paraquat poisoningD P Dearnaley, M F Martin
The Journal of Urology|January 1, 1992
Re: Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation)J D Fosså, D P Dearnaley
The Practitioner|June 1, 1981
Tumour markers. Their role in clinical medicineD P Dearnaley, R C Coombes
Pageof 19

Showing results (11-20 of 185) with videos related to

Sort By:
Pageof 19
The Journal of Physiology|December 1, 1970
The effect of cocaine and normetanephrine on the overflow of noradrenaline from the isolated blood-perfused cat spleenH Cripps, D P Dearnaley
Arzneimittel-Forschung|September 1, 1971
A technique for measuring exploratory activity in rats: some effects of chlorpromazine and chlordiazepoxideJ Cole, D P Dearnaley
Cancer Treatment Reviews|June 6, 2003
Radical radiotherapy for prostate cancerC C Parker, D P Dearnaley
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 13, 2019
Seven or less Fractions is Not the Standard of Care for Intermediate-Risk Prostate CancerA C Tree, D P Dearnaley
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 27, 2007
Question of dose, fractionation and technique: ingredients for testing hypofractionation in prostate cancer--the CHHiP trialV S Khoo, D P Dearnaley
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1993
Prostate cancer: pelvic nodes revisited--sites, incidence and prospects for treatment with radiotherapyA J Neal, D P Dearnaley
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 3, 1999
The management of PSA failure after radical radiotherapy for localized prostate cancerC C Parker, D P Dearnaley
Lancet (London, England)|January 21, 1978
Plasmapheresis for paraquat poisoningD P Dearnaley, M F Martin
The Journal of Urology|January 1, 1992
Re: Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation)J D Fosså, D P Dearnaley
The Practitioner|June 1, 1981
Tumour markers. Their role in clinical medicineD P Dearnaley, R C Coombes
Pageof 19